In this paper，the product status，market profile and developing trend of the implant-in-the-eye device are investigated and analyzed，and the industry development situation of the implant-in-front device is fully demonstrated. The clinical trial of collar-and-button artificial cornea has been carried out all over the country，and the evaluation of curative effect has exceeded the standard of World Health Organization. Bio-conjunctival products are expected to start multi-center clinical research in 2020. At present，there is no tissue engineering cornea product that can be industrialized and obtained the clinical application license of the State Food and Drug Administration，but the research in this field is of great importance. At present，there are three major acellular corneal stroma/graft，and there are two biologic amniotic membrane manufacturers for ocular surface therapy. As a long-term implantable medical equipment manufacturer of Class Ⅲ，these production enterprises can only go on the road of sustained and steady development by combining their own characteristics，effectively building production systems suitable for supervision，improving quality control level and strengthening risk management consciousness.